Will Trump administration weaken protections for human research subjects?

5 Oct, 2026

The Trump administration appears poised to weaken protections for people enrolled in some clinical trials. In a little-noticed posting on a government website tracking agency regulations, the U.S. Department of Health and Human Services (HHS) announced an upcoming “deregulatory” move that would revise the Common Rule, a federal policy that governs aspects of human research including informed consent, data sharing, and special protections for vulnerable participants such as prisoners or pregnant people.

The July posting contains few details but says the Common Rule’s framework, last updated in 2017, “no longer reflects the realities of modern research” and “imposes unnecessary burdens and unclear requirements, particularly for minimal-risk studies.” HHS declined to answer questions about the timing of the forthcoming rule, which will require a public comment period before implementation.

“It sounds like they’re doing something serious, and they could go pretty far,” says Jerry Menikoff, a bioethicist at the National University of Singapore and former director of HHS’s Office for Human Research Protections (OHRP), which oversees the Common Rule.

Source